Due to Adverse Market Conditions and Travel Challenges we are placing all the May 20-21 content into a digital feed (StreamYard) for most of the same sessions, but all on May 21. Further, we will begin asking our great group of experts to join CBD OutLook All-Digital week Friday (2-4 CST) all-digital 3 sergment. One segment will be all MedMJ to Sked 3 related, a second 40 min. weekly module on latest FedHempBan bill analysis with Susan Burns weekly with attorney drop in. Third segment leads with MSO business and MandA, financial performance and innovation (New SKUs)
9 Panels & 6 Research Papers = Timely Insights
From medical cannabis legalization to the business and science of CBD innovations. and the start of the Medicare CBD pilot for the nation's 62 million seniors--Be There!
Robert Hoban
ARROWS/ CTrust
Mary Jane Oatman -- Indigenous Cannabis Industry Association
Joe Hodas
WANA Brands/ Wanderous Past Pres.
Jordan Wellington Co-Founder, Strategies 64
Jason Adeistone
Partner, Harris Slikowski
Jonathan Miller
General Counsel, US Hemp Roundtable
2026 MedMJ Milestones to Sked3
Compiled by Americans for Safe Access--
2. DEA: The new Notice of Hearing on Proposed Rulemaking (NHPRM): Docket No. DEA-1362; Attorney General Order No. 6753-2026: "Every 'interested person' as defined in 21 CFR 1300.01(b) as 'any person adversely affected or aggrieved by any rule or proposed rule issuable' who wishes to participate in the hearing shall file a written notice of intention to participate. Electronic filing may be made as a PDF attachment via email to the Drug Enforcement Administration, Attn: Administrator at nprm@dea.gov, on or before 11:59 p.m. Eastern Time on May 24, 2026.
May 24, 2026: Deadline for "interested party" submissions to NHPRM
June 26, 2026: Deadline for medical cannabis businesses to register with the DEA
June 29, 2026: New Administrative hearing set to begin for broader marijuana rescheduling.
July 15, 2026: The new administrative hearing will conclude, according to the DOJ Press Release
November 2026: Changes to federal hemp law are expected to take effect, which may affect some hemp-derived cannabinoid products. This is separate from the DOJ/DEA medical cannabis order but may affect patients using full-spectrum CBD or other hemp-derived products. 7 U.S.C. § 1639o — Hemp Definition
December 26, 2026: 6-month target for DEA to approve medical cannabis registrations
3 Keynotes-9 Panels-7 Meals & Networking
Use code "CBD4mg" at Eventbrite Checkout Below and save $45 per ticket.
Contact us
Telephone: +1 303-824=9265
E-mail: DrLloyd@CBD4mg.com
Princeton Research (West420 News Weekly)
1360 So. Wadsworth Blvd. Denver, CO 80232